Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences miRNA and Non-coding RNA

Melanie Lehman's Biography



Melanie Lehman, Research Scientist, Queensland University of Technology

Dr Lehman is a Research Fellow (Computational Biology) at the Australian Prostate Cancer Research Centre-Queensland (APCRC-Q) and a Member of the Institute of Health and Biomedical Innovation at Queensland University of Technology in Brisbane, Australia. Dr Lehman completed her BSc in cell biotechnology at the University of Alberta in 1998 (Edmonton, Canada). She has university level training in software engineering, math and statistics, and six years of work experience in bioinformatics prior to starting her PhD. In 2011, she completed her PhD focused on prostate cancer and computational biology at the University of British Columbia (Vancouver Prostate Centre, Vancouver, Canada). Dr Lehman joined the APCRC-Q in 2012 and is currently co-leader of the Transcriptomics Section of a Movember Revolutionary Team Award (led by Prof Colleen Nelson), a joint collaboration between prostate cancer researchers in Australia, Canada and Ireland. Her research is focused on the complexity of condition-specific transcription including alternative protein-coding isoforms and non-coding RNA. She utilizes computational approaches to analyze and integrate profiling data (RNAseq, smallRNAseq and microarray) from in vitro cell culture, xenograft and patient models to study treatment resistance in advanced prostate cancer.

Melanie Lehman Image

Identification of Long Non-coding RNAs in Prostate Cancer by RNA-seq

Friday, 10 May 2013 at 11:15

Add to Calendar ▼2013-05-10 11:15:002013-05-10 12:15:00Europe/LondonIdentification of Long Non-coding RNAs in Prostate Cancer by RNA-seqSELECTBIOenquiries@selectbiosciences.com

We have used RNA-seq with de novo transcriptome assembly to identify long non-coding RNAs in prostate cancer cells, including non-coding RNAs overlapping—and often mistaken for—protein-coding RNAs.  A complete picture of the prostate cancer transcriptome is critical in developing durable therapies for men with late stage prostate cancer.


Add to Calendar ▼2013-05-09 00:00:002013-05-10 00:00:00Europe/LondonmiRNA and Non-coding RNASELECTBIOenquiries@selectbiosciences.com